Abstract
Surgical site infections (SSIs), which represent approximately 22 % of all healthcare-related infections, are associated with significant healthcare costs and medical morbidity. When an SSI occurs, direct inpatient medical costs typically double. Infection rates for implantable pain therapies (spinal cord stimulation and intrathecal drug delivery) have been reported in the range of 2–8 %. Recently, substantial emphasis has been placed on reducing the incidence of SSIs. Although SSIs may occur at any location, most infections related to implantable pain therapies occur at the generator site or the intrathecal pump pocket.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Deer TR, Provenzano DA. Recommendations for reducing infection in the practice of implanting spinal cord stimulation and intrathecal drug delivery devices: a physician’s playbook. Pain Physician. 2013;16:E125–8.
Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg. 2011;253:1082–93.
Suggested Reading
Biswas D, Bible JE, Whang PG, Simpson AK, Grauer JN. Sterility of C-arm fluoroscopy during spinal surgery. Spine (Phila Pa 1976). 2008;33:1913–7.
Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg. 2009;249:551–6.
Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res. 2013;471:2383–99.
Darouiche RO, Wall Jr MJ, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18–26.
Follett KA, Boortz-Marx RL, Drake JM, DuPen S, Schneider SJ, Turner MS, et al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology. 2004;100:1582–94.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–78.
Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, Parvizi J. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am. 2010;92 Suppl 2:36–46.
Mok JM, Pekmezci M, Piper SL, Boyd E, Berven SH, Burch S, et al. Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early postoperative infectious complications. Spine (Phila Pa 1976). 2008;33:415–21.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Provenzano, D.A. (2016). Perioperative Precautions for Infection Control. In: Deer, T., Pope, J. (eds) Atlas of Implantable Therapies for Pain Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2110-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2110-2_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2109-6
Online ISBN: 978-1-4939-2110-2
eBook Packages: MedicineMedicine (R0)